These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 9688144)
1. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144 [TBL] [Abstract][Full Text] [Related]
2. Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53. Iannettoni MD; Lee SS; Bonnell MR; Sell TL; Whyte RI; Orringer MB; Beer DG Ann Thorac Surg; 1996 Nov; 62(5):1460-5; discussion 1465-6. PubMed ID: 8893584 [TBL] [Abstract][Full Text] [Related]
3. Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas. Nambu Y; Iannettoni MD; Orringer MB; Beer DG Mol Carcinog; 1998 Dec; 23(4):234-42. PubMed ID: 9869452 [TBL] [Abstract][Full Text] [Related]
4. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
5. Identification of intestinal-type Barrett's metaplasia by using the intestine-specific protein villin and esophageal brush cytology. MacLennan AJ; Orringer MB; Beer DG Mol Carcinog; 1999 Feb; 24(2):137-43. PubMed ID: 10078941 [TBL] [Abstract][Full Text] [Related]
6. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma. Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152 [TBL] [Abstract][Full Text] [Related]
7. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma. Hughes SJ; Nambu Y; Soldes OS; Hamstra D; Rehemtulla A; Iannettoni MD; Orringer MB; Beer DG Cancer Res; 1997 Dec; 57(24):5571-8. PubMed ID: 9407969 [TBL] [Abstract][Full Text] [Related]
8. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359 [TBL] [Abstract][Full Text] [Related]
9. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
10. Decrease in Le(x) expression in esophageal adenocarcinomas arising in Barrett's epithelium. Engel U; McCombs R; Stranahan P; Pettijohn D; Hage E Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):245-8. PubMed ID: 9107429 [TBL] [Abstract][Full Text] [Related]
11. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma. Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942 [TBL] [Abstract][Full Text] [Related]
12. Multifocal heterogeneity in villin and Ep-CAM expression in Barrett's esophagus. Kumble S; Omary MB; Fajardo LF; Triadafilopoulos G Int J Cancer; 1996 Mar; 66(1):48-54. PubMed ID: 8608965 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis. Yacoub L; Goldman H; Odze RD Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315 [TBL] [Abstract][Full Text] [Related]
14. Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications. Weiss MM; Kuipers EJ; Hermsen MA; van Grieken NC; Offerhaus J; Baak JP; Meuwissen SG; Meijer GA J Pathol; 2003 Feb; 199(2):157-65. PubMed ID: 12533828 [TBL] [Abstract][Full Text] [Related]
15. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844 [TBL] [Abstract][Full Text] [Related]
17. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry. Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405 [TBL] [Abstract][Full Text] [Related]
18. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro. De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793 [TBL] [Abstract][Full Text] [Related]
19. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia. Cameron AJ; Souto EO; Smyrk TC Am J Gastroenterol; 2002 Jun; 97(6):1375-80. PubMed ID: 12094853 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Morris CD; Armstrong GR; Bigley G; Green H; Attwood SE Am J Gastroenterol; 2001 Apr; 96(4):990-6. PubMed ID: 11316217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]